Ge Healthcare Life

Merck to use prefabricated adjustable cleanrooms at $300m FLEx center

18-Jun-2019 By Maggie Lynch

Reconfigurable cleanroom pods to be used at Merck’s formulation laboratory to address increasing demands of diverse patient populations.

Pharma 2020 has activated Russian biomanufacturing tech market says GE Healthcare

23-Sep-2016 By Gareth Macdonald

Government efforts to encourage local drug production have “activated” the Russian biomanufacturing technology market according to GE Healthcare.

GE sets up in Istanbul in bid to capture a share of Turkish tech market

14-Nov-2014 By Gareth Macdonald

Turkey’s efforts to increase local biopharmaceutical production have prompted GE Healthcare Life Sciences to set up a biopharmaceutical technology training centre in Istanbul.

GE launches compact automated purification system

27-Nov-2013 By Dan Stanton

GE Healthcare has launched an automated protein purification system it says can save researchers and labs time and decrease the risk of manual error.

GE launches new programmable bioreactor for seed chain and process dev

22-Nov-2013 By Gareth Macdonald

GE Healthcare has launched new single-use, bioreactor for seed train and process development operations and mAb production.

GE to buy Xcellerex in latest biomanufacturing-focused investment

08-Mar-2012 By Gareth Macdonald

GE Healthcare has announced plans to buy US production tech firm Xcellerex, continuing its efforts to build its biomanufacturing offering.

GE and M+W team on plant and tech biologics production solution

14-Dec-2011 By Gareth Macdonald

GE Healthcare and M+W Group aim to capture a share of the rapidly expanding global biologics market with a new plant and manufacturing tech partnership.

GE Healthcare to invest in biomanufacturing tech

19-Sep-2011 By Gareth Macdonald

GE Healthcare will expand its range of biomanufacturing technologies under a new oncology-focused investment project.

SSB and GE sign patent licensing deal for biomanufacturing techs

13-Sep-2011 By Gareth Macdonald

Sartorius Stedium Biotech (SSB) and GE Healthcare Life Sciences say new cross licensing deal will aid development of their respective biomanufacturing tech offerings.